Home Contact Sitemap

Surgical Pioneering Inc.

Propelling Life Through Surgical Innovation

Our Focus

img

Coronary Artery Augmentation

Coronary artery disease refers to obstructions developing inside the arteries that nourish the heart muscle, shown by injection of x-ray dyes. Bypass grafts act as tubular bridges to bring blood into a coronary artery downstream from an obstruction. When the arteries are too diffusely obstructed, or are too narrow in diameter, bypass graft surgery is unsuccessful reqiuring re-operation or even impossible to perform.

 

By preventing the need for most clotted graft re-operations, the “Coronary Artery Augmentation” (CAA) system will expectedly save over 4,000 lives and over $7 billion dollars of health care money annually. Additionally, the CAA system opens up a whole new field of heart surgery never before possible, the discovery and correction of obstructive coronary artery disease in arteries too small to be seen on x-ray and also too small to be operated upon by either bypass graft surgery or balloon angioplasty. This will prevent heart attacks and deaths especially in diabetic patients who characteristically have small artery obstructive disease, and who make up 40% of the patients having coronary artery bypass graft surgery.

“Coronary Artery Augmentation” (CAA) system will expectedly save over 4,000 lives and over $7 billion dollars of health care money annually.


Innovation Development Pipeline

Future Projects:
  • Innovation 1
  • Innovation 2

Surgical Pioneering is committed to bettering life saving surgical procedures and techniques. Several additional innovations are in the pipeline for future development.